Chief Executive Officer – International Pharmaceutical Federation

Catherine Duggan is the Chief Executive Officer of the International Pharmaceutical Federation and is responsible for visionary leadership, support, development, advocacy and growth across the 150+ member organisations and the four million pharmacists and pharmaceutical scientists FIP represents. FIP is a founder member of the World Professions Health Alliance (represents 41 million health professionals across medicine, nursing, dentistry, physiotherapy and pharmacy) and Dr Duggan is chair of the CEOs of WHPA in 2024. FIP signed a MOU with WHO in May 2019 at the World Health Assembly meeting which builds on the formal established relationship WHO and FIP have held since 1948 and secures how pharmacy contributes globally to Primary Health Care to deliver Universal Health Coverage. By signing the profession up to the Astana declaration in 2018, pharmacy will present evidence of impact to health ministers of pharmacy’s impact (science, practice, workforce) during 2024. This involves data through the FIP observatory, support through the FIP platform for provision and our FIP wide programmes to deliver the 21 FIP development goals. Dr Duggan has published widely and presented at national and international meetings and has a wealth of people and programme management experience. She is a recognised leader across the profession working with many networks within and across the profession and, more widely, health and business. Catherine has worked in community, primary care, hospital and academia. Between 2007 and 2009, Catherine was the Chair of the United Kingdom Clinical Pharmacy Association and then an elected member of the Council of the RPSGB. A double graduate from the School of Pharmacy, University of London (now UCL School of Pharmacy), Dr Duggan received a Fellowship of the School in 2013 and was awarded an honorary Professorship from the School of Pharmacy, University of Nottingham in 2018. She holds Fellowships of both the Royal Pharmaceutical Socity the Royal Society of Arts. Catherine was awarded the Nagai International Woman Scientist Award in May 2021, on behalf of the Academy of Pharmaceutical Science and Technology, Japan and is the current European Chair for United States Pharmacopeia European Charter. Catherine is an avid film lover, enjoys singing and travelling, fine wine and dining, sports and dancing.

Regina Mariam Namata Kamoga is an Executive Director, for Community Health and Information Network (CHAIN) for Uganda,an organization that promotes the empowerment of people living with,and affected by,HIV and AIDS and non-communicable diseases. Ms. Kamoga works on patients’rights, particularly the rights of persons with HIV/AIDS,TB, malaria and non-communicable diseases, and capacity building for NGOs and community based organizations on governance and policy issues,health literacy and access. Ms. Kamoga’s work involves building and strengthening networks in collaboration with other organizations at the international, national and community level to address issues of patient safety and patient-centered healthcare.

Anthony B. Kapeta works as a Legal Officer for AUDA-NEPAD(African Union Development Agency). He supports health-related programs and leads the activities of the Technical Committee on Medicines Policy and Regulatory Reforms under the African Medicine Regulatory Harmonization Programme (AMRH). Anthony also coordinates the AUDA-NEPAD’s interventions against substandard and Falsified medical products and is the focal person for the development of the Continental plan against SF medical products. In addition, Anthony B. Kapeta provides expertise to support the development of pooled procurement mechanisms of medicines within the African continent and coordinates AUDA-NEPAD’s country interventions to support development or the review of legislations on medicines and related substances (including legislation on SF). He was part of the drafting team of the Reference Manual on legislation of SFMP, under the European Union Project Medisafe. Prior to AUDA-NEPAD, Anthony B. Kapeta has worked as Legal Advisor for Doctors Without Borders (MSF) Canada in Cameroon, Legal Associate for the African Union Commission ( Office of the Legal Counsel) in Ethiopia, and as a Registered Lawyer at the Kinshasa Bar in Congo ( Democratic Republic).

Hussain Jafri is the Chief Executive Officer of the World Patients Alliance (WPA) which is the largest umbrella organization working across all disease areas. He also serves as a Assistant Professor at the Institute of Patient Safety Research, University of Kalisz, Poland, where he advances academic work in patient safety and healthcare quality. He serves on the WHO Civil Society Commission Steering Committee, strengthening engagement between WHO and civil society worldwide. He is also a member of the Advisory Group for WHO’s Patients for Patient Safety (PFPS) program, where he previously served as Vice Chair. At the national level, Hussain founded the Pakistan Patient Safety Initiative and was appointed by the Government of Punjab as Provincial Focal Person on Patient Safety and Quality, where he led the development of provincial healthcare policies and services. He also established Alzheimer’s Pakistan, the country’s first national association for Alzheimer’s disease and related dementias, inspired by his experience as a caregiver for his grandfather. With over three decades of advocacy, Hussain has worked extensively with governments, patient groups, and international organizations. He is a member of the Person and Family-Centred Advisory Council (PFCAC) of ISQua and serves on the taskforce of the Global Alliance of Partners for Pain Advocacy (GAPPA). An accomplished speaker, Hussain has addressed international conferences on patient safety, caregiving, person-centred healthcare, and advocacy. He has published widely in peer-reviewed journals and holds a PhD from the University of Leeds, UK, with research focused on the prevention of genetic disorders. He also served as Director General of the Punjab Thalassemia & Other Genetic Disorders Prevention & Research Institute.

Chair of the Fight the Fakes Alliance Since September, 2017, Andrea manages the partnerships division of the World Heart Federation (WHF), a Geneva, Switzerland-based NGO representing the global cardiovascular community. The programs created with private sector companies committed to the fight against cardiovascular disease support the WHF mission of “Heart Health for All”. Her activities include leveraging the World Heart Day global CVD awareness platform, promoting the Global Circulatory Health Summit thought leadership platform, as well as engaging with industry in support of a variety of field activities and CVD Roadmaps designed to improve heart health globally. A dual citizen of Switzerland and the United States, Andrea spent 16 years of her career at DuPont, in a variety of business development & marketing management positions. She is a graduate of Hofstra University, New York (USA) with a Bachelor of Science Degree in Applied Economics and holds an MBA degree from Università Luigi Bocconi, Milan, Italy.

Technical Officer Market Surveillance and Control (MSC) team, WHO

Pernette Bourdillon Esteve is a Technical Officer Market Surveillance and Control (MSC) team at the World Health Organization (WHO). She leads strategic initiatives to strengthen global surveillance and response systems for SF medical products, managing the Global Surveillance and Monitoring System database and guiding policy development through data analysis. With over 15 years of international public health experience, Pernette has worked across global policy and technical domains. Her expertise spans incident management, strategy design, data interoperability, and training. Prior to WHO, she held roles at the United Nations Office against Drugs and Crime, UNITAID, the French Ministry of Foreign Affairs, and in the private sector, consistently focusing on global health. She holds a Bachelor's degree in public health, a Masters in Political Science and is currently pursuing a PhD in global health, focusing on the interoperability of datasets linking SF medical products, diseases, and populations.

Fight the Fakes Alliance Goodwill Ambassador, CMCOMMS Supply Chain Quality Assurance Expert

Wilson Chandomba, CSCL is an award-winning Health and Humanitarian Supply Chain Expert, GSDP (Good Storage and Distribution Practices) Specialist, and a Certified Supply Chain Leader (CSCL) with more than 26 years of experience in pharmaceutical quality assurance and logistics across Africa. He is the Founder and Managing Consultant of CMCOMMS Supply Chain Quality Assurance and the Southern Africa Regional Lead for the International Association of Public Health Logisticians (IAPHL). He received the Outstanding Achievement Award in Humanitarian & Health Supply Chain Management at the 2025 Africa Supply Chain Excellence Awards (ASCEA), for pioneering the use of GSDP as an affordable and accessible safeguard against SFMPs. Wilson has trained over 2,000 professionals—from regulators and logisticians to customs officers, freight forwarders, and frontline health workers

Andrew Spiegel has nearly two decades of experience in the patient advocacy arena. Spiegel co-founded the Colorectal Cancer Alliance, now the leading US based national patient advocacy organization dedicated to colon cancer. Mr. Spiegel, an attorney, besides being a co-founder of the organization and longtime board member of the Alliance became CEO in January of 2008 and he ran the CCA for nearly 5 years, before undertaking his next venture, the Global Colon Cancer Association (GCCA). Currently, Spiegel is co-founder and executive director of the GCCA, an international patient advocacy organization. This organization is an international community of nearly 50 colon cancer patient advocacy organizations and stakeholders dedicated to end the worldwide suffering of the 3rd leading cause of cancer deaths. In addition to his work in the colon cancer community, Spiegelis an active advocate for health care policies both in the US and now worldwide. He is a co-founder and currently serves on the steering committee of the Alliance for Safe Biologic Medicines (ASBM). He is on the Board of Directors, and in December 2014 was elected to Chair, of the Digestive Disease National Coalition (DDNC),a founding member of the Coalition to Increase Clinical Trial Participation. In addition to his work in the colon cancer community, Spiegelis an active advocate for health care policies both in the US and now worldwide. He is a co-founder and currently serves on the steering committee of the Alliance for Safe Biologic Medicines (ASBM). He is on the Board of Directors, and in December 2014 was elected to Chair, of the Digestive Disease National Coalition (DDNC),a founding member of the Coalition to Increase Clinical Trial Participation. Spiegel is a 1986 graduate of Temple University in Philadelphia where he earned a Bachelor’s degree in Political Science with minors in English and Philosophy. He is a 1989 graduate of the Widener University School of Law. After working for a Philadelphia litigation firm, Spiegel opened his own law firm in 1995.